Child and Adolescent Psychopharmacology

Adler, L. A., Resnick, S., Kunz, M., & Devinsky, O. (1995). Open label trial of venlafaxine in adults with attention deficit disorder. Psychopharmacology Bulletin, 31, 785–788.PubMedGoogle Scholar

Aladjem, M., Wohl, R., Biochis, H., Orda, S., Lotan, D., & Freedman, S. (1982). Desmopressin in nocturnal enuresis. Archives of Disease in Childhood, 57, 137–140.PubMedCrossRefGoogle Scholar

Alessi, N., Naylor, M., Ghaziuddin, M., & Zubieta,J. (1994). Update on lithium carbonate therapy in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 291–304.PubMedCrossRefGoogle Scholar

Aman, M. G., Marks, R. E., Turbott, S. H., Wilshier, C. P., & Merry, S. N. (1991). Methylphenidate and thioridazine in the treatment of intellectually subaverage children: Effects on cognitive-motor performance. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 816–824.PubMedGoogle Scholar

Ambrosini, P., Bianchi, M., Rabinovich, H., & Elia, J. (1993). Antidepressant treatments in children and adolescents: I. Affective disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 1–6.PubMedCrossRefGoogle Scholar

Anderson, J. C., Williams, S., McGee, R., & Silva, P. A. (1987). DSM-II1 disorders in preadolescent children: Prevalence in a large sample from the general population. Archives of General Psychiatry, 44, 69–76.PubMedCrossRefGoogle Scholar

Apter, A., Ratzoni, G., King, R., Weizman, A., Iancu, I., Binder, M., & Riddle, M. (1994). Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 342–348.PubMedCrossRefGoogle Scholar

August, G. J., Raz, N., & Baird, T. D. (1985). Effects of fenfluramine on behavioral, cognitive, and affective disturbances in autistic children. Journal of Autism and Developmental Disorders, 15, 97–107.PubMedCrossRefGoogle Scholar

Baldessarini, R. J. (1985). Chemotherapy in psychiatry. Cambridge, MA: Harvard University Press.Google Scholar

Baldessarini, R. J. (1996). Chemotherapy in psychiatry (2nd ed.). Cambridge, MA: Harvard University Press.Google Scholar

Barkley, R. A. (1990). Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment. New York: Guilford Press.Google Scholar

Barkley, R. A., McMurray, M. B., Edelbrock, C. S., & Robbins, K. (1990). Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systematic, placebo-controlled evaluation. Pediatrics, 86, 184–192.PubMedGoogle Scholar

Bernstein, G. A. (1991). Comorbidity and severity of anxiety and depressive disorders in a clinic sample. fournalofthe American Academy of Child and Adolescent Psychiatry, 30, 43–50.CrossRefGoogle Scholar

Bernstein, G. A., & Borchardt, C. M. (1991). Anxiety disorders of childhood and adolescence: A critical review. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 519–532.PubMedCrossRefGoogle Scholar

Bernstein, G. A., Garfinkel, B., & Borchardt, C. (1987). Imipramine versus alprazolam for school phobia. Paper presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Washington, DC.Google Scholar

Bernstein, G. A., Garfinkel, B. D., & Borchardt, C. M. (1990). Comparative studies of pharmacotherapy for school refusal. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 773–781.PubMedCrossRefGoogle Scholar

Biederman, J. (1987). Clonazepam in the treatment of prepubertal children with panic-like symptoms. Journal of Clinical Psychiatry, 48(Suppl.), 38–41.PubMedGoogle Scholar

Biederman, J. (1991). Psychopharmacology in children and adolescents. In J. Wiener (Ed.), Comprehensive textbook of child and adolescent psychiatry (pp. 545–570). Washington, DC: American Psychiatric Association.Google Scholar

Biederman, J., Baldessarini, R. J., Wright, V., Knee, D., Harmatz,J., & Goldblatt, A. (1989). A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder II: Serum drug levels and cardiovascular findings. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 903–911.PubMedCrossRefGoogle Scholar

Biederman, J., Newcorn, J., & Sprich, S. (1991). Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. American Journal of Psychiatry, 148, 564–577.PubMedGoogle Scholar

Biederman, J., Thisted, R., Greenhill, L., & Ryan, N. (1994). Safety of desipramine in children. Progress Notes of the American Society of Clinical Psychopharmacology, 45 2–4.Google Scholar

Bird, B. R., Canino, G., Rubio-Stipec, M., Gould, M. S., Ribera, J., Sesman, M., Woodbury, M., Huertas-Goldman, S., Pagan, A., Sanchez-Lacay, A., & Moscoso, M. (1988). Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico. Archives of General Psychiatry, 45, 1120–1126.PubMedCrossRefGoogle Scholar

Birkasova, M., Birkas, O., Flynn, M.J., & Cort, J. H. (1978). Desmopressin in the management of nocturnal enuresis in children: A double-blind study. Pediatrics, 62, 970–974.PubMedGoogle Scholar

Birmaher, B., Waterman, S., Ryan, N., Cully, M., Balach, L., & Ingram, J. (1994). Fluoxetine for childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 993–997.PubMedCrossRefGoogle Scholar

Campbell, M. (1988). Fenfluramine treatment of autism. Journal of Child Psychology and Psychiatry and Allied Disciplines, 29, 1–10.CrossRefGoogle Scholar

Campbell, M., Adams, P., Perry, R., Spencer, E. K., & Overall, J. E. (1988). Tardive and withdrawal dyskinesia in autistic children: A prospective study. Psychopharmacology Bulletin, 24, 251–255.PubMedGoogle Scholar

Campbell, M., Anderson, L. T., & Green, W. H. (1983). Behavior-disordered and aggressive children: New advances in pharmacotherapy. Journal of Developmental and Behavioral Pediatrics, 4, 265–271.PubMedGoogle Scholar

Campbell, M., Anderson, L., Small, A., Adams, P., & Gonzalez, N. (1993). Naltrexone in autistic children: Behavioral symptoms and attentional learning. Journal of the American Academy of Child and Adolescent Psychiatry, 32,1283–1291.PubMedCrossRefGoogle Scholar

Campbell, M., & Palij, M. (1985). Measurement of side effects including tardive dyskinesia. Psychopharmacology Bulletin, 21, 1063–1080.PubMedGoogle Scholar

Campbell, M., Perry, R., & Green, W. H. (1984). Use of lithium in children and adolescents. Psychosomatics, 25, 95–101.PubMedCrossRefGoogle Scholar

Campbell, M., Small, A. M., Green, W. H., Jennings, S. J., Perry, R., Bennett, W. G., & Anderson, L. (1984). Behavioral efficacy of haloperidol and lithium carbonate: A comparison in hospitalized aggressive children with conduct disorder. Archives of General Psychiatry, 41, 650–656.PubMedCrossRefGoogle Scholar

Campbell, M., & Spencer, E. K. (1988). Psychopharmacology in child and adolescent psychiatry: A review of the past five years. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 269–279.CrossRefGoogle Scholar

Carlson, G. A. (1990). Bipolar disorders in children and adolescents. In B. D. Garfinkel, G. A. Carlson, & E. B. Weller (Eds.), Psychiatric disorders in children and adolescents (pp. 21–36). Philadelphia: Saunders.Google Scholar

Carlson, G., Fennig, S., & Bromet, E. (1994). The confusion between bipolar disorder and schizophrenia in youth: Where does it stand in the 1990’s?Journal of the American Academy of Child and Adolescent Psychiatry, 33, 453–460.CrossRefGoogle Scholar

Carlson, G. A., & Kashani,J. H. (1988). Manic symptoms in a non-referred adolescent population. Journal of Affective Disorders, 15, 219–226.PubMedCrossRefGoogle Scholar

Carlson, G. A., & Strober, M. (1978). Manic-depressive illness in early adolescence: A study of clinical and diagnostic characteristics in six cases. Journal of the American Academy of Child and Adolescent Psychiatry, 17, 138–153.CrossRefGoogle Scholar

Casat, C. D., Pleasants, D. Z., & Van Wyck Fleet, J. (1987). A double-blind trial of bupropion in children with attention deficit disorder. Psychopharmacology Bulletin, 23, 120–122.PubMedGoogle Scholar

Chandran, K. (1994). ECG and clonidine. Journal of theAmerican Academy of Child and Adolescent Psychiatry, 33, 1351–1352.CrossRefGoogle Scholar

Coffey, B., Frazier, J., & Chen, S. (1992). Comorbidity, Tourette syndrome, and anxiety disorders. In T. N. Chase, A. J. Friedhoff, & D.J. Cohen (Eds.), Advances in neurology, ?burette syndrome: Genetics, neurobiology,and treatment (pp. 95–104). New York: Raven Press.Google Scholar

Coffey, B., Shader, R. I., & Greenblatt, D. J. (1983). Pharmacokinetics of benzodiazepines and psycho-stimulants in children. Journal of Clinical Psychopharmacology, 3, 217–225.PubMedCrossRefGoogle Scholar

Cohen, D.J. (1990). Tourette’s syndrome: Developmental psychopathology of a model neuropsychiatric disorder of childhood. Lecture presented at the 27th Annual Institute of Pennsylvania Hospital.Google Scholar

Cohen, D.J., Bruun, R. D., & Leckman, J. F. (Eds.). (1988). Tourette’s syndrome and tic disorders: Clinical understanding and treatment. New York: Wiley.Google Scholar

Cohen, D., & Leckman, J. (1994). Developmental psychopathology and neurobiology of Tourette’s syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 2–15.PubMedCrossRefGoogle Scholar

Conners, C., Casat, C., Gualtieri, C., Weller, E., Reader, M., Reiss, A., Weller, R., Khayrallah, M., & Ascher, J. (1996). Bupropion hydrbchloride in attention deficit disorder with hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1314–1321.PubMedCrossRefGoogle Scholar

Connor, D. (1993). Beta-blockers for aggression: The pediatric experience. Journal of Child and Adolescent Psycho-pharmacology, 3, 99–114.CrossRefGoogle Scholar

Connor, D., Ozbayrak, K. R., Kusiak, K., Caponi, A., & Melloni, R. (1997). Combined pharmacotherapy in children and adolescents in a residential treatment center. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 248–254.PubMedCrossRefGoogle Scholar

Costello, E., Edelbrock, C., Costello, A., Dulcan, M., & Burns, B. (1988). Psychopathology in pediatric primary care: The new hidden morbidity. Journal of Pediatrics, 82, 415–424.Google Scholar

Cunningham, L., Borison, R., Carmen, J., Chouinard, G., Crowder, J., Diamond, B., Fischer, D., & Hearst, E. (1994). A comparison of venlafaxine, trazodone, and placebo in major depression. Journal of Clinical Psycho-pharmacology, 14, 99–106.Google Scholar

EIia,J., Borcherding, B. G., Potter, W. Z., Mefford, I. N., Rapoport, J. L., & Keysor, C. S. (1990). Stimulant drug treatment of hyperactivity: Biochemical correlates. Clinical Pharmacology and Therapeutics, 48, 57–66.CrossRefGoogle Scholar

Emslie, G., Kowatch, R., Costello, L., Travis, G., & Pierce, L. (1995). Double-blind study of fluoxetine in depressed children and adolescents. Proceedings of the American Academy of Child and Adolescent Psychiatry, XI, 41–42.Google Scholar

Fankhauser, M. P., Karumanchi, V. C., German, M. L., Yates, A., & Karumanchi, S. D. (1992). A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. Journal of Clinical Psychiatry, 53, 77–82.PubMedGoogle Scholar

FDA. (1982). Use of approved drugs of unlabeled indications. Psychopharmacology Bulletin, 18, 5–20.Google Scholar

Frazier, J., Giedd, J., Hambruger, S., Albus, K., Kaysen, D., Vaituzis, C., Rajapakse, J., Lenane, M., McKenna, K., Jacobsen, L., Gordon, C., Brier, A., & Rapoport, J. (1996). Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia. Archives of General Psychiatry, 53, 617–624.PubMedCrossRefGoogle Scholar

Frazier, J., Giedd, J., McKenna, K., Lenane, M., Jih, D., & Rapoport, J. (1994). An open trial of clozapine in 11 adolescents with childhood onset schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 658–663.PubMedCrossRefGoogle Scholar

Frick, P., Lahey, B., Loeber, R., Tannenbaum, L., Horn, Y., Christ, M., Hart, E., & Hanson, K. (1993). Oppositional defiant disorder and conduct disorder: A meta-analytic review of factor analyses and cross-validation in a clinical sample. Clinical Psychology Review, 13, 319–340.CrossRefGoogle Scholar

Gadow, K. D., Sverd, J., Sprafkin, J., Nolan, E. E., & Ezor, S. N. (1995). Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Archives of General Psychiatry, 52, 444–455.PubMedCrossRefGoogle Scholar

Gammon, G. D., & Brown, T. E. (1993). Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. Journal of Child and Adolescent Psychopharmacology, 3,1-10.PubMedCrossRefGoogle Scholar

Geller, B. (1994). Phenomenology and course of pediatric bipolar disorders (Grant Application No. I ROI MH53063–01). Washington University School of Medicine.Google Scholar

Geller, B., Cooper, T. B., Graham, D. L., Fetner, H. H., Marsteller, F. A., & Wells, J. M. (1992). Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6–12-year-olds with major depressive disorder: Outcome; nortriptyline and hydroxy-nortriptyline plasma levels; EKG,BP and side effects measurements. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 34–44.PubMedCrossRefGoogle Scholar

Geller, B., Fox, L. W., & Fletcher, M. (1993). Effect of tricyclic antidepressants on switching to mania and on the onset of bipolarity in depressed 6- to 12-year-olds. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 43–50.PubMedCrossRefGoogle Scholar

Geller, B., Sun, K., Zimerman, B., Luby, J., Frazier, J., & Williams, M. (1995). Complex and rapid-cycling in bipolar children and adolescents: A preliminary study. Journal of Affective Disorders, 22, 1–10.Google Scholar

Geller, D., Biederman, J., Reed, E. D., Spencer, T.,& Wilens, T. E. (1995). Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 36–44.PubMedCrossRefGoogle Scholar

Gittelman, R., & Klein, D. F. (1971). Controlled imipramine treatment of school phobia. Archives of General Psychiatry, 25, 204–207.CrossRefGoogle Scholar

Gittelman, R., Landa, B., Mattes, J., & Klein, D. (1988). Methylphenidate and growth in hyperactive children: A controlled withdrawal study. Archives of General Psychiatry, 45, 1127–1130.CrossRefGoogle Scholar

Gittelman, R., & Mannuzza, S (1988). Hyperactive boys almost grown up: III. Methylphenidate effects on ultimate height. Archives of General Psychiatry, 45, 1131–1134.CrossRefGoogle Scholar

Gittelman-Klein, R. (1980). Diagnosis and drug treatment of childhood disorders. In D. F. Klein, R. Gittelman, F. Quitkin, & A. Rifkin (Eds.), Diagnosis and drug treatment of psychiatric disorders: Adults and children (pp. 576–775). Baltimore: Williams & Wilkins.Google Scholar

Goodwin, F., & Jamison, K. (1990). Manic-depressive illness. London: Oxford University Press.Google Scholar

Gordon, C. T., Frazier, J., McKenna, K., Lenane, M., Jih, D., & Rapoport, J. (1994). Childhood-onset schizophrenia: An NIMH study in progress. Schizophrenia Bulletin, 20, 697–712.PubMedCrossRefGoogle Scholar

Graae, F., Milner, J., Rizzotto, L., & Klein, R. (1994). Clonazepam in childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 372–376.PubMedCrossRefGoogle Scholar

Greenhill, L. L., & Osman, B. B. (1991). Ritalin: Theory and patient management. New York: Mary Ann Liebert.Google Scholar

Hunt, R. D. (1987). Treatment effects of oral and transdermal clonidine in relation to methylphenidate: An open pilot study in ADD-H. Psychopharmacology Bulletin, 23, 111–114.PubMedGoogle Scholar

Hunt, R., Arnsten, A., & Asbell, M. (1995). An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 50–54.PubMedCrossRefGoogle Scholar

Hunt, R. D., Minderaa, R. B., & Cohen, D. J. (1985). Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial. Journal of the American Academy of Child Psychiatry, 24, 617–629.PubMedCrossRefGoogle Scholar

Institute of Medicine. (1990). Research on children and adolescents with mental, behavioral, and developmental disorders. Washington, DC: National Institute of Mental Health.Google Scholar

Jankovic,J. (1993). Deprenyl in attention deficit associated with Tourette’s syndrome. Archives of Neurology, 50, 286–288.PubMedCrossRefGoogle Scholar

Jensen, P. S., Shervette, R. E., Xenakis, S. N., & Richters, J. (1993). Anxiety and depressive disorders in attention deficit hyperactivity disorder with hyperactivity: New findings. American Journal of Psychiatry, 150, 1203–1209.PubMedGoogle Scholar

Jensen, P., Vitiello, B., Leonard, H., & Laughren, T. (1994). Child and adolescent psychopharmacology: Expanding the research base. Psychopharmacology Bulletin, 30, 3–8.PubMedGoogle Scholar

Kashani, J. H., & Orvaschel, H. (1988). Anxiety disorders in mid-adolescence: A community sample. American Journal of Psychiatry, 145, 960–964.PubMedGoogle Scholar

Kashani,J. H., & Sherman, D. D. (1989). Mood disorders in children and adolescents. In A. Tasman, R. E. Hales, & A. J. Frances (Eds.), Review of psychiatry (pp. 197–217). Washington, DC: American Psychiatric Association.Google Scholar

Kemph, J., DeVane, C., Levin, G., Jarecke, R., & Miller, R. (1993). Treatment of aggressive children with clonidine: Results of an open pilot study. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 577–581.PubMedCrossRefGoogle Scholar

Klein, R. G. (1987). Pharmacotherapy of childhood hyperactivity: An update. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress (pp. 1215–1224). New York: Raven Press.Google Scholar

Klein, R. G., & Bessler, A. W. (1992). Stimulant side effects in children. In J. M. Kane & J. A. Lieberman (Eds.), Adverse effects ofpsychotropic drugs (pp. 470–496). New York: Guilford Press.Google Scholar

Klorman, R., Brumaghim, J. T., Salzman, L. F., Strauss, J., Borgstedt, A. D., McBride, M. C., & Loeb, S. (1989). Comparative effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features. Psychopharmacology Bulletin, 25, 109–113.PubMedGoogle Scholar

Kovacs, M., Akiskal, H., Gatsonis, C., & Parrone, P. (1994). Childhood-onset dysthymic disorder: Clinical features and prospective naturalistic outcome. Archives of General Psychiatry, 51, 365–374.PubMedCrossRefGoogle Scholar

Kovacs, M., Feinberg, T. L., Crouse-Novak, M., Paulauskas, S. L., & Finkelstein, R. (1984). Depressive disorders in childhood: I. A longitudinal prospective study of characteristics and recovery. Archives of General Psychiatry, 41, 229–237.PubMedCrossRefGoogle Scholar

Kumra, S., Frazier, J. A., & Jacobsen, L. (1996). Childhood onset schizophrenia: A double-blind clozapine trial. Archives of General Psychiatry, 56, 1090–1097.CrossRefGoogle Scholar

Kutcher, S., Boulos, C., Ward, B., Marton, P., Simeon, J., Ferguson, H. B., Szalai, J., Katic, M., Roberts, N., Dubois, C., & Reed, K. (1994). Response to desipramine treatment in adolescent depression: A fixed-dose, placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 686–694.PubMedCrossRefGoogle Scholar

Lazarus, A., Mann, S. C., & Caroff, S. N. (1989). The neuroleptic malignant syndrome and related conditions. Washington, DC: American Psychiatric Association.Google Scholar

Leckman, J. F., Hardin, M. T., Riddle, M. A., Stevenson, J., Ort, S., & Cohen, D. J. (1991). Clonidine treatment of Gilles de la Tourette’s syndrome. Archives of General Psychiatry, 48, 324–328.PubMedCrossRefGoogle Scholar

Leckman, J. F., Riddle, M. A., & Cohen, D. J. (1988). Pathobiology of Tourette’s syndrome. In D. J. Cohen, R. D. Bruun, & J. E Leckman (Eds.), Toureue’s syndrome and tic disorders: Clinical understanding and treatment (pp. 103–118). New York: Wiley.Google Scholar

Leckman, J. F., Walkup, J. T., Riddle, M. A., Towbin, K. E., & Cohen, D. J. (1987). Tic disorders. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress (pp. 1239–1254). New York: Raven Press.Google Scholar

Leonard, H., & Rapoport, J. (1989). Anxiety disorders in childhood and adolescence. In A. Tasman, R. Hales, & A. Frances (Eds.), Review of psychiatry (pp. 162–179). Washington, DC: American Psychiatric Association.Google Scholar

Leonard, H. L., Swedo, S. E., Rapoport, J. L., Koby, E. V., Lenane, M. C., Cheslow, D. L., & Hamburger, S. D. (1989). Treatment of obsessive compulsive disorder with clomipramine and desipramine in children and adolescents: A double-blind crossover comparison. Archives of General Psychiatry, 46, 1088–1092.PubMedCrossRefGoogle Scholar

Levenson, J. L. (1985). Neuroleptic malignant syndrome. American journal of Psychiatry, 142, 1137–1145.PubMedGoogle Scholar

Loeber, R., Lahey, B. B., & Thomas, C. (1991). Diagnostic conundrum of oppositional defiant disorder and conduct disorder. Journal of Abnormal Psychology, 100, 379–390.PubMedCrossRefGoogle Scholar

Mandoki, M. (1995). Risperidone treatment of children and adolescents: Increased risk of extrapyramidal side effects? Journal of Child and Adolescent Psychopharmacology, 5, 49–67.CrossRefGoogle Scholar

Mannuzza, S., Klein, R. G., Bessler, A., Malloy, P., & LaPadula, M. (1993). Adult outcome of hyperactive boys: Educational achievement, occupational rank, and psychiatric status. Archives of General Psychiatry, 50, 565–576.PubMedCrossRefGoogle Scholar

March, J., & Leonard, H. (1996). Obsessive-compulsive disorder in children and adolescents: A review of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1265–1273.PubMedCrossRefGoogle Scholar

Mattes, J. A., Rosenberg, J., & Mays, D. (1984). Carbamazepine versos propranolol in patients with uncontrolled rage outbursts: A random assignment study. Psychopharmacology Bulletin, 20, 98–100.PubMedGoogle Scholar

McElroy, S. L., Keck, P. E., Pope, H. G., & Hudson, J. I. (1992). Valproate in the treatment of bipolar disorder: Literature review and clinical guidelines. Journal of Clinical Psychopharmacology, 12, 42S.PubMedCrossRefGoogle Scholar

McElroy, S., Strakowski, S., West, S., Keck, P., & McConville, B. (1997). Phenomenology of adolescent and adult mania in hospitalized patients with bipolar disorder. American journal of Psychiatry, 154, 44–49.PubMedGoogle Scholar

Medical Letter . (1990). Sudden death in children treated with a tricyclic antidepressant. 32(816), 37–40.Google Scholar

Meltzer, H. Y. (Ed.). (1987). Psychopharmacology: The third generation of progress. New York: Raven Press.Google Scholar

Murphy, J. V., Groover, R. V., & Hodge, C. (1993). Hepatotoxic effects in a child receiving valproate and carnitine. Journal of Pediatrics, 123, 318–320.PubMedCrossRefGoogle Scholar

Pataki, C., Carlson, G., Kelly, K., Rapport, M., & Biancaniello, T. (1993). Side effects of methylphenidate and desipramine alone and in combination in children. American Journal of Psychiatry, 32, 1065–1072.Google Scholar

Patrick, K. S., Mueller, R. A., Gualtieri, C. T., & Breese, G. R. (1987). Pharmacokinetics and actions of methylphenidate. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress (pp. 1387–1395). New York: Raven Press.Google Scholar

Pelham, W., Greenslade, K., Vodde-Hamilton, M., Murphy, D., Greenstein, J., Gnagy, E., Guthrie, K., Hoover, M., & Dahl, R. (1990). Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: A comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics, 86, 226–237.PubMedGoogle Scholar

Physicians’ desk reference (48th ed.). (1994). Montvale, NJ: Medical Economics.Google Scholar

Popper, C. (Ed.). (1987). Psychiatric pharmacosciences of children and adolescents. Washington, DC: American Psychiatric Association.Google Scholar

Popper, C. W. (1995). Combining methylphenidate and clonidine: Pharmacologic questions and news reports about sudden death. Journal of Child and Adolescent Psychopharmacology, 5, 157–166.CrossRefGoogle Scholar

Pratt, D. S., & Dubois, R. S. (1990). Hepatotoxicity due to pemoline (Cylert): A report of two cases. Journal ofPediatric Gastroenterology, 10, 239–241.CrossRefGoogle Scholar

Preskorn, S., Alderman, J., Chung, M., Harrison, W., Mes-sign, M., & Harris, S. (1994). Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine. Journal of Clinical Psychopharmacology, 14, 90–98.PubMedGoogle Scholar

Preskorn, S. H., Weller, E. B., Weller, R. A., & Glotzbach, E. (1983). Plasma levels of imipramine and adverse effects in children. American Journal of Psychiatry, 140, 1332–1335.PubMedGoogle Scholar

Puig-Antich, J. (1982). Major depression and conduct disorder in prepuberty. Journal of the American Academy of Child and Adolescent Psychiatry, 21, 118–128.CrossRefGoogle Scholar

Puig-Antich, J., Perel, J. M., Lupatkin, W., Chambers, W.J., Tabrizi, M. A., King, J., Goetz, R., Davies, M., & Stiller, R. L. (1987). imipramine in prepubertal major depressive disorders. Archives of General Psychiatry, 44, 81–89.PubMedCrossRefGoogle Scholar

Rapoport, J. (1994). Clozapine and child psychiatry. Journal of Child and Adolescent Psychopharmacology, 4, 1–3.CrossRefGoogle Scholar

Rapoport, J. L., Buschbaum, M. S., Zahn, T. P., Weingartner, H., Ludlow, C., & Mikkelsen, E. J. (1978). Dextroamphetamine: Cognitive and behavioral effects in prepubertal boys. Science, 199, 560–563.PubMedCrossRefGoogle Scholar

Rapoport, J. L.., Mikkelsen, E. J., & Zavadil, A. P. (1978). Plasma imipramine and desmethylimipramine concentration and clinical response in childhood enuresis. Psychopharmacology Bulletin, 14, 60–61.PubMedGoogle Scholar

Rapoport, J. L., Quinn, P. Bradbard, G., Riddle, D., & Brooks, E. (1974). Imipramine and methylphenidate treatment of hyperactive boys: A double-blind comparison. Archives of General Psychiatry, 30, 789–793.Google Scholar

Rapoport, J., Swedo, S., & Leonard, H. (1992). Childhood obsessive compulsive disorder. Journal of Clinical Psychiatry, 53, 11–16. Google Scholar

Rapport, M., Carlson, G., Kelly, K., & Pataki, C. (1993). Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function. Journal of theAmerican Academy of Child and Adolescent Psychiatry, 32, 333–342.CrossRefGoogle Scholar

Ratey, J. J. (1991). Mental retardation: Developing pharmacotherapies. Washington, DC: American Psychiatric Association.Google Scholar

Ratey, J. J., Mikkelsen, E. J., Smith, G. B., Upadhyaya, A., Zuckerman, H. S., Martell, D., Sorgi, P. Polakoff, S., & Bemporad, J. (1986). Beta-blockers in the severely and profoundly mentally retarded. Journal of Clinical Psycho-pharmacology, 6, 103–107.Google Scholar

Realmuto, G. M., Jensen, J., Klykylo, W., Piggott, L., Stubbs, G., Yuwiler, A., Geller, E., Freeman, B. J., & Ritvo, E. (1986). Untoward effects of fenfluramine in autistic children. Journal of Clinical Psychopharmacology, 6, 350–355.PubMedCrossRefGoogle Scholar

Remschmidt, H., Schulz, E., & Martin, P. (1994). An open trial of clozapine in thirty-six adolescents with schizophrenia. Journal of Child and Adolescent Psychopharmacology, 4, 31–41. Google Scholar

Riddle, M., Geller, B., & Ryan, N. (1993). Case study: Another sudden death in a child treated with desipramine. Journal of theAmerican Academy of Child and Adolescent Psychiatry, 32, 792–797.CrossRefGoogle Scholar

Riddle, M. A., Hardin, M. T., Cho, S. C., Woolston, J. L., & Leckman, J. F. (1988). Desipramine treatment of boys with attention-deficit hyperactivity disorder and tics: Preliminary clinical experience. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 811–814.PubMedCrossRefGoogle Scholar

Riddle, M. A., Nelson, J. C., Kleinman, C. S., Rasmussen, A., Leckman, J. F., King, R. A., & Cohen, D. J. (1991). Sudden death in children receiving norpramin: A review of three reported cases and commentary. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 104–108.PubMedCrossRefGoogle Scholar

Riddle, M., Scahill, L., King, R., Hardin, M., Anderson, G., Ort, S., Smith, J., Leckman, J., & Cohen, D. (1992). Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 1062–1069.PubMedCrossRefGoogle Scholar

Ritvo, E. R., Freeman, B. J., Yuwiler, A., Geller, E., Schroth, P., Yokota, A., Mason, B. A., August, G.J., Klykylo, W., & Leventhal, B. (1986). Fenfluramine treatment of autism: UCLA collaborative study of 81 patients at nine medical centers. Psychopharmacology Bulletin, 22, 133–140.PubMedGoogle Scholar

Rosenbaum, J. F. (1982). The drug treatment of anxiety. New England Journal of Medicine, 306, 401–404.PubMedCrossRefGoogle Scholar

Roy-Byrne, P. P., & Cowley, D. S. (1991). Benzodiazepines in clinical practice: Risks and benefits. Washington, DC: American Psychiatric Association.Google Scholar

Ryan, N. D., Meyer, V., Dachille, S., Mazzie, D., & Puig-Antich, J. (1988). Lithium antidepressant augmentation in TCA-refractory depression in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 371–376.PubMedCrossRefGoogle Scholar

Ryan, N. D., Puig, A.J., Rabinovich, H., Fried, J., Ambrosini, P., Meyer, V., Torres, D., Dachille, S., & Mazzie, D. (1988). MAOIs in adolescent major depression unresponsive to tricyclic antidepressants. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 755–758.PubMedCrossRefGoogle Scholar

Ryan, N. D., Puig-Antich, J., Ambrosini, P., Rabinovich, H., Robinson, D., Nelson, B., Iyengar, S., & Twomey, J. (1987). The clinical picture of major depression in children and adolescents. Archives of General Psychiatry, 44, 854–861.PubMedCrossRefGoogle Scholar

Shader, R. I., & Greenblatt, D. J. (1993). Use of benzodiazepines in anxiety disorders. New England Journal of Medicine, 5, 1398–1405.Google Scholar

Shapiro, A. K., Shapiro, E., & Fulop, G. (1987). Pimozide treatment of tic and Tourette disorders. Pediatrics, 79, 1032–1039.PubMedGoogle Scholar

Simeon, J., Caney, N., Wiggins, D., Milin, R., & Hosenbocus, S. N. (1995). Risperidone effects in treatment resistant adolescents: Preliminary case reports. Journal of Child and Adolescent Psychopharmacology, 5, 69–79.CrossRefGoogle Scholar

Simeon, J. G., Dinicola, V. F., Ferguson, H. B., & Copping, W. (1990). Adolescent depression: A placebo-controlled fluoxetine treatment study and follow-up. Progress in Neuropsychopharmacological and Biological Psychiatry, 14, 791–795.CrossRefGoogle Scholar

Simeon, J. G., Ferguson, H. B., Knott, V., Roberts, N., Gauthier, B., Dubois, C., & Wiggins, D. (1992). Clinical, cognitive, and neurophysiological effects ofalprazolam in children and adolescents with over anxious and avoidant disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 29–35.PubMedCrossRefGoogle Scholar

Simeon, J. G., Ferguson, H. B., & Van Wyck Fleet, J. (1986). Bupropion effects in attention deficit and conduct disorders. Canadian Journal of Psychiatry, 31, 581–585.Google Scholar

Singer, S., Brown, J., Quaskey, S., Rosenberg, L., Mellits, E., & Denckla, M. (1994). The treatment of attention-deficit hyperactivity disorder in Tourette’s syndrome: A double-blind placebo-controlled study with clonidine and desipramine. Pediatrics, 95, 74–81.Google Scholar

Spencer, T., Biederman, J., Harding, M., O’Donnell, D., Faraone, S., & Wilens, T. (1996). Growth deficits in ADHD children revisited: Evidence for disorder-associated growth delays? Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1460–1469.PubMedCrossRefGoogle Scholar

Spencer, T., Biederman, J., Kerman, K., Steingard, R., & Wilens, T. (1993). Desipramine in the treatment of children with tic disorder or Tourette’s syndrome and attention deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 354–360.PubMedCrossRefGoogle Scholar

Spencer, T. J., Biederman, J., Steingard, R., & Wilens, T. (1993). Bupropion exacerbates tics in children with attention deficit hyperactivity disorder and Tourette’s disorder. Journal of theAmerican Academy of Child and Adolescent Psychiatry, 32, 211–214.CrossRefGoogle Scholar

Spencer, T., Biederman, J., Wilens, T., Harding, M., O’Donnell, D., & Griffin, S. (1996). Pharmacotherapy of attention deficit disorder across the life cycle. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 409–432.PubMedCrossRefGoogle Scholar

Spencer, T., Biederman, J., Wright, V., & Danon, M. (1992). Growth deficits in children treated with desipramine: A controlled study. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 235–243.CrossRefGoogle Scholar

Spencer, T., Wilens, T., Biederman, J., Fararone, S., Ablon, S., Lapey, K. (1995). A double blind, crossover comparison of methylphenolates and placebo in adults with childhood onset attention deficit hyperactivity disorder. Archives of General Psychiatry, 52, 434–443.PubMedCrossRefGoogle Scholar

Steingard, R., Biederman, J., Spencer, T., Wilens, T., & Gonzalez, A. (1993). Comparison of clonidine response in the treatment of attention deficit hyperactivity disorder with and without comorbid tic disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 350–353.PubMedCrossRefGoogle Scholar

Steingard, R., Goldberg, M., Lee, D.,& DeMaso, D. (1994). Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD. Journal of theAmerican Academy of Child and Adolescent Psychiatry, 33, 394–399.CrossRefGoogle Scholar

Strober, M., Morrell, W., Lampert, C., & Burroughs, J. (1990). Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: A naturalistic study. American Journal of Psychiatry, 147, 457–461.PubMedGoogle Scholar

Strober, M., Schmidt-Lackner, S., Freeman, R., Bower, S., Lampert, C., & DeAntonio, M. (1995). Recovery and relapse in adolescents with bipolar affective illness: A five-year naturalistic, prospective follow-up. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 724–731.PubMedCrossRefGoogle Scholar

Swanson, J. M., Granger, D., & Kliewer, W. (1987). Natural social behaviors in hyperactive children: Dose effects of methylphenidate. Journal of Consulting and Clinical Psychology, 55, 187–193.PubMedCrossRefGoogle Scholar

Swanson, J. M., McBurnett, K., Christian, D. L., & Wigal, T. (1995). Stimulant medications and the treatment of children with ADHD. In T. H. 011endick & R. Prinz (Eds.), Advances in clinical child psychology (Vol. 17, pp. 265–322). New York: Plenum Press.Google Scholar

Swedo, S. E., Leonard, H. L., & Rapoport, J. I.. (1992). Childhood-onset obsessive compulsive disorder. Psychiatric Clinics of North America, 15, 767–775.PubMedGoogle Scholar

Tran, P., Beasley, C., Tollefson, G. S., & Satterless, W. (1994). Clinical efficacy and safety of increasing doses of olanzapine: A new atypical antipsychotic agent. Paper presented at the American College of Neuropharmacology, Puerto Rico.Google Scholar

Vitiello, B., Behar, D., Malone, R., Delaney, M. A., Ryan, P.J., & Simpson, G. M. (1988). Pharmacokinetics of lithium carbonate in children. Journal of Clinical Psychopharmacology, 8, 355–359.Google Scholar

Weiss, R., Stein, M., Trommer, B., & Refetoff, S. (1993). Attention-deficit hyperactivity disorder and thyroid function. Journal of Pediatrics, 123, 539–545.Google Scholar

Weller, E. B., Weller, R. A., & Fristad, M. A. (1986). Lithium dosage guide for prepubertal children: A preliminary report. Journal of theAmerican Academy of Child Psychiatry, 25, 92–95.CrossRefGoogle Scholar

Weller, E., Weller, R., & Fristad, M. (1995). Bipolar disorder in children: Misdiagnosis, underdiagnosis, and future directions. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 709–714.PubMedCrossRefGoogle Scholar

Werry, J. (1994). Pharmacotherapy of disruptive behavior disorders. Child and Adolescent Psychiatric Clinics of North America, 3, 321–342.Google Scholar

Werry, J. S., McClellan, J. M., & Chard, L. (1991). Childhood and adolescent schizophrenic, bipolar, and schizoaffective disorders: A clinical and outcome study. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 457–465.PubMedCrossRefGoogle Scholar

Wilder, B. J. (1992). Pharmacokinetics of valproate and carbamazepine. Journal of Clinical Psychopharmacology, 12, 64S.Google Scholar

Wilens, T., & Biederman, J. (1992). The stimulants. In D. Schaffer (Ed.), Psychiatric clinics of North America (pp. 191–222). Philadelphia: Saunders.Google Scholar

Wilens, T., Biederman, J., Baldessarini, J., Geller, B., Schleifer, D., Birmaher, B., & Spencer, T (1996). The cardiovascular effects of tricyclic antidepressants in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1491–1501.PubMedCrossRefGoogle Scholar

Wilens, T. E., Biederman, J., Baldessarini, R. J., Puopolo, P. R., & Flood, J. G. (1992). Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine. Journal of theAmerican Academy of Child and Adolescent Psychiatry, 31, 691–698.CrossRefGoogle Scholar

Wilens, T., Biederman, J., & Spencer, T. (1994). Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 424–426.PubMedCrossRefGoogle Scholar

Wilens, T., Spencer, T., Biederman, J., & Schleifer, D. (1997). Nefazadone for juvenile mood disorders: Case series. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 481–485.CrossRefGoogle Scholar

Wilens, T., Spencer, T., Biederman, J., Wozniak, J., & Connor, D. (1995). Combined pharmacotherapy: An emerging trend in pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 110–112.PubMedCrossRefGoogle Scholar

Williams, D. T, Mehl, R., Yudofsky, S., Adams, D., & Roseman, B. (1982). The effect of propranolol on uncontrolled rage outbursts in children and adolescents with organic brain dysfunction. Journal of the American Academy of Child and Adolescent Psychiatry, 21, 129–135.CrossRefGoogle Scholar

Wozniak, J., & Biederman, J. (1995). Childhood mania exists (and coexists) with ADHD. American Society of Clinical Psychopharmacology Progress Notes, 6, 4–5.Google Scholar

Wozniak, J., & Biederman, J. (1996). A pharmacological approach to the quagmire of comorbidity in juvenile mania. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 826–828.PubMedCrossRefGoogle Scholar

Wozniak, J., Biederman, J., Kiely, K., Ablon, S., Faraone, S. V., Mundy, E., & Mennin, D. (1995). Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 867–876.PubMedCrossRefGoogle Scholar

Zametkin, A., Rapoport, J. L., Murphy, D. L., Linnoila, M., & Ismond, D. (1985). Treatment of hyperactive children with monoamine oxidase inhibitors: I. Clinical efficacy. Archives of General Psychiatry, 42, 962–966.PubMedCrossRefGoogle Scholar